Clarivate

DECEMBER 6, 2022

In a fiercely competitive U.S. While marquee IDNs attract national headlines, these smaller systems reflect how markets are adjusting to an increasingly value-based and competitive landscape. ChristianaCare’s future expansion plans could escalate the competition between Highmark and UPMC. ChristianaCare, Wilmington, Delaware.

Networking 52

Networking Healthcare Healthcare Competition 52

PM360

APRIL 22, 2024

With an ever- increasing demand for their time and attention, it is more difficult than ever for biopharma representatives to convey their message to the physician audience. In one survey, only 12% of HCPs said they felt biopharma companies are very effective at providing HCP education and training to them.

Education 59

Education Physicians Healthcare Healthcare 59

Pharmaceutical Technology

JUNE 20, 2023

At $48 a share for the South San Francisco,California-based biopharma, Lilly is paying a 40% premium on top of the 30-day average trading price. GlobalData is the parent company of Pharmaceutical Technology DICE’s novel oral therapeutic candidates positioned it as an attractive prospect for acquisition.

Prospecting 52

Prospecting Competition Biopharma Marketing 52

Clarivate

OCTOBER 7, 2021

Competition is imminent as the CheckMate-76K trial evaluating Bristol-Myers Squibb’s Opdivo in stage IIB-C melanoma patients is also poised to enter this setting. This novel antibody-drug conjugate (ADC)ADC faces much competition, should it be approved. Abstract LBA52. Abstract 944P.

Patients 91

Patients Safety Marketing Physicians 91

Pharmaceutical Technology

MARCH 31, 2023

This year, competition in the obesity therapeutic landscape has ramped up as biotechs aim to follow the success of blockbuster drugs from Novo Nordisk , Eli Lilly and more. In the panel, Melanie Senior, a biopharma reporter at Nature Biotech also pointed out reimbursement issues for obesity drugs.

Training 52

Training Competition Biopharma Prospecting 52

Pharmaceutical Technology

MARCH 21, 2023

Vetter Pharma-Fertigung GmbH & Co KG is contracted for the parenteral manufacture and packaging for the vascular endothelial growth factor (VEGF) inhibitor, while Biogen and KBI Biopharma are producing the biologic API. Baxter Biopharma Solutions is contracted for the parenteral manufacture and packaging of Enhertu.

Manufacturing 59

Manufacturing Pharmaceutical Biopharma FDA 59

Pharmaceutical Technology

JUNE 16, 2023

Synthetic biology biopharma Biostar Pharma announced is ready to advance its utidelone injectable (UTD1) in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC), following approval from the US Food and Drug Administration (FDA) for the study.

FDA 52

FDA Food and Drug Administration Patients Marketing 52

Pharmaceutical Technology

MAY 3, 2023

The proposed facility would play a vital role in fulfilling demand in the Asia Pacific region while representing an important hub for further biopharma industry development in South Korea.” We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Government 52

Government Electronics Biopharma Prospecting 52

Pharmaceutical Technology

JANUARY 15, 2023

Baxter Biopharma Solutions, Fareva SA, BSP Pharmaceuticals SpA, and Takeda Pharmaceuticals are manufacturing the parenteral portion of the ADC. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Manufacturing 52

Manufacturing Pharmaceutical FDA Pharma 52

Zymewire

FEBRUARY 8, 2024

Skip to a topic Axonis' journey and purpose The impact of the economic client on emerging biopharma The place of Artificial Intelligence in drug development & discovery Working with NASA Relationships with CROs, CDMOs, and other service providers What made you want to start Axonis? sending neurons to space.

Competition 52

Competition Leads Patients Marketing 52

Pharmaceutical Technology

MARCH 24, 2023

GC Biopharma is also running a Phase III trial for its live-attenuated vaccine GC-3107A to replace BCG. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Pharma 64

Pharma Side effects Marketing Biopharma 64

Pharmaceutical Technology

APRIL 16, 2023

This is an exciting prospect: oncology, and immuno-therapy in particular, is a driving force behind biotech R&D, with new cancer therapies and molecules accounting for nearly 40% 1 of the industry’s development pipeline. SHL Medical knows that widening the use of autoinjectors for volumes of up to 5.0 References 1.

Medical 52

Medical Medicine Patients Manufacturing 52

Pharmaceutical Technology

FEBRUARY 27, 2023

Baxter Biopharma Solutions has been contracted for the ADC’s parenteral manufacture and packaging. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Manufacturing 52

Manufacturing Pharmaceutical Pharma FDA 52